Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Heart disease is killing more women in Pakistan than previously understood, with female patients experiencing higher mortality rates, more severe symptoms and delayed diagnoses compared to men, ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

The researchers determined that women who began menstruating before age 10 were more likely to develop obesity, high blood pressure, diabetes, heart problems and reproductive problems like ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Warning signs of an unhealthy heart, though, can lurk — not so quietly — in its many complex sounds. That's why FIU researchers Joshua Hutcheson and Valentina Dargam have come up with a way to "listen ...

Piedmont has expanded access to outpatient heart failure management with a new heart failure clinic at Piedmont Newton ...